Poxel SA announced the initiation of a phase 1b trial designed to investigate PXL065 for the treatment of nonalcoholic steatohepatitis in patients without cirrhosis, according to a press release.
Would you like to receive email reminders to complete your saved activities from Healio CME?
Activity saved! You'll receive reminders to complete your saved activities from Healio CME.
